NCT06920550

Brief Summary

This is a data collection and machine learning accuracy testing project that aims to a) collect training data to enhance, by machine learning, an artificial intelligence (AI) algorithm for measuring length in infants and young children and b) test the accuracy of the AI algorithm by comparing the AI predicted length with the gold standard measured length. Images and videos will be collected by care givers and healthcare professionals, together with physical length measurements. These data will be used to train the AI algorithm and to explore potential improvements. Other data to be collected is user experience feedback.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2024

Geographic Reach
3 countries

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

December 20, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 9, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

April 9, 2025

Status Verified

February 1, 2025

Enrollment Period

12 months

First QC Date

December 11, 2024

Last Update Submit

April 1, 2025

Conditions

Keywords

artificial intelligencelengthweightalgorithm

Outcome Measures

Primary Outcomes (3)

  • Accuracy length AI

    Accuracy of the Length AI vs length gold standard (WHO methodology with length board in cm) assessed using several different parameters: the bias (cm), agreement and reliability measures, mean absolute error (cm), mean absolute percentage error (%), percentiles of the absolute error (cm), and root mean square error (cm).

    Date of enrolment, at baseline

  • Accuracy caregiver length

    Accuracy of the caregiver measured length (own preferred methodology in cm) vs gold standard measured length (WHO methodology with length board in cm), assessed by same parameters as mentioned in the first primary outcome measure.

    Date of enrolment, at baseline

  • Accuracy caregiver vs AI length

    Accuracy of the caregiver measurements (self preferred methodology in cm) vs Length AI by same parameters as mentioned in the first primary outcome measure.

    Date of enrolment, at baseline

Secondary Outcomes (4)

  • Accuracy weight AI

    Date of enrolment, at baseline

  • Accuracy caregiver weight

    Date of enrolment, at baseline

  • Ease of use tool

    Date of enrolment, at baseline

  • Acceptability tool

    Date of enrolment, at baseline

Study Arms (1)

Children 0-24 months

Children aged 0-24 months of age with no structural abnormalities of the lower limbs or orthopedic conditions

Eligibility Criteria

Age0 Months - 24 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children aged 0 to 24 months.

You may qualify if:

  • Infants/young children aged 0 to 24 months old at enrolment;
  • Caregiver(s) have access to the internet and a smartphone or tablet to complete questionnaires, take images and videos, and upload these;
  • Written informed consent from one or both caregivers (according to local laws) or legally acceptable representative(s) aged ≥ 18 years at enrolment.

You may not qualify if:

  • Children unable to undergo length or weight measurements when applying standardized techniques recommended by the WHO (e.g. infants/children with structural abnormalities of the lower limbs or orthopaedic conditions (e.g. club foot, hip dysplasia)).
  • Research staff's uncertainty about the caregiver's ability or willingness to complete the study according to the instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Franciscus Gasthuis

Rotterdam, Netherlands

NOT YET RECRUITING

Ginemedica

Wroclaw, Poland

NOT YET RECRUITING

Hospital Universitario Puerta del Mar

Cadiz, Spain

RECRUITING

Hospital Universitario de Jerez dela Frontera

Jerez de la Frontera, Spain

RECRUITING

MeSH Terms

Conditions

Body Weight

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Danone Global Research and Innovation Center

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2024

First Posted

April 9, 2025

Study Start

December 20, 2024

Primary Completion

December 15, 2025

Study Completion

March 1, 2026

Last Updated

April 9, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Not applicable due to the nature of the project

Locations